丽珠医药(01513.HK)对公司组织架构进行调整
格隆汇8月28日丨丽珠医药(01513.HK)公布,于2019年8月28日,公司董事会会议审议通过《关于公司组织架构调整的议案》,为适应公司经营发展的需要,进一步完善公司的治理结构,提升公司运营及管理水平,同意对公司组织架构进行调整。
审议通过《关于提名公司第九届董事会独立非执行董事候选人的议案》,经公司董事会提名委员会对本次独立非执行董事候选人任职资格的审核及建议,公司董事会提名田秋生先生和黄锦华先生为公司第九届董事会独立非执行董事候选人。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.